Tech Company Financing Transactions
BioProtect Funding Round
MVM Life Science Partners, Almeda Ventures and Consensus Business Group invested in a $28 million funding round for BioProtect. This venture round was announced on 9/27/2023.
Transaction Overview
Company Name
Announced On
9/27/2023
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the funds to Commercialize its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy. Proceeds from this financing will support US commercialization of the BioProtect Balloon Implant System, which recently received FDA clearance for rectal protection during radiation therapy for prostate cancer.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8 Tsor St.,
Tzur Yigal, 4486200
IL
Tzur Yigal, 4486200
IL
Phone
Website
Email Address
Overview
BioProtect is a technology platform company that provides innovative biodegradable spacing solutions. BioProtect's first application, commercially available in the US and Europe, is the BioProtect Balloon Implant System, a new generation spacer designed to provide optimal, consistent, and reproducible protection to the rectum during prostate cancer radiation therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Itay Barnea
Browse more venture capital transactions:
Prev: 9/27/2023: Machine Discovery venture capital transaction
Next: 9/27/2023: Lumu venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs